Changes in the spectrum of ocular disease during the COVID-19 pandemic in late 2022 in the Hubei Province

Related articles

1. Clinical efficacy of casirivimab and imdevimab in preventing COVID-19 in the Omicron BA.5 subvariant epidemic: a retrospective study

   This article has 13 authors:

   1. Mariko Ohtani
   2. Takuya Yokoo
   3. Taito Miyazaki
   4. Hiroshi Yasuda
   5. Eriko Nishikawa
   6. Manabu Tomida
   7. Mayumi Tsukada
   8. Emi Sato
   9. Shinobu Hirayama
   10. Hinako Murakami
   11. Sadako Yoshizawa
   12. Takahiro Matsumoto
   13. Kazuhiro Tateda

2. Epidemiological and Clinical Characteristics, Transmissibility, and Associated Factors of HAdV in Wuhan, China (2023-2024): Insights from a Multi-Center Public Health Surveillance System

   This article has 10 authors:

   1. Tianmu Chen
   2. Yunkang Zhao
   3. Banghua Chen
   4. Hongfeng Zhao
   5. Ying Peng
   6. Yunan Wan
   7. Yuanyuan Zhang
   8. Yanhua Su
   9. Jia Rui
   10. Zeyu Zhao

3. Systematic differences were identified for symptoms of Omicron infected individuals between early and late stage of the COVID-19 pandemic in China

   This article has 16 authors:

   1. Congying Yang
   2. Yi Zhang
   3. Ying Yang
   4. Baibing Mi
   5. Mingwang Shen
   6. Yunpeng Nian
   7. Jinyu Wang
   8. Suixia Cao
   9. Jingchun Liu
   10. Pouria Abolfazli
   11. Hao Huang
   12. Zhongxi Wei
   13. Lixi Liu
   14. Qian Wu
   15. Tianxiao Zhang
   16. Shaobai Zhang